Nephros (NASDAQ:NEPH) Stock Price Down 6.6% – What’s Next?

Nephros Inc. (NASDAQ:NEPH)’s stock price dropped 6.6% during trading on Tuesday . The stock traded as low as $3.48 and last traded at $3.53. Approximately 26,497 shares traded hands during trading, an increase of 43% from the average daily volume of 18,537 shares. The stock had previously closed at $3.78.

Nephros Trading Down 6.6%

The stock has a market cap of $37.42 million, a PE ratio of 50.44 and a beta of 1.09. The firm has a fifty day simple moving average of $3.30 and a two-hundred day simple moving average of $2.24.

Nephros (NASDAQ:NEPH) last posted its quarterly earnings data on Thursday, May 15th. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $4.88 million during the quarter, compared to analysts’ expectations of $3.67 million. Nephros had a return on equity of 9.43% and a net margin of 5.16%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Nephros stock. Topline Capital Management LLC bought a new position in Nephros Inc. (NASDAQ:NEPH) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned 3.98% of Nephros at the end of the most recent quarter. 41.10% of the stock is owned by institutional investors and hedge funds.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.